Literature DB >> 20725546

Management of high-risk cutaneous squamous cell carcinoma.

Lorraine Jennings1, Chrysalyne D Schmults.   

Abstract

Cutaneous squamous cell carcinoma is an increasing public health concern, representing the second most common cancer in the United States. High-risk cutaneous squamous cell carcinoma represents a subgroup of this disease, where patients are at higher risk of metastasis and death. To date, there are no accepted criteria for defining or managing these patients. This review discusses the current state of knowledge of high-risk cutaneous squamous cell carcinoma and outlines reasonable management strategies based on available data.

Entities:  

Year:  2010        PMID： 20725546      PMCID： PMC2921745     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  85 in total

1.  Perineural spread of cutaneous squamous and basal cell carcinoma: CT and MR detection and its impact on patient management and prognosis.

Authors:  L S Williams; A A Mancuso; W M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

2.  Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.

Authors:  Catherine A Harwood; Mary Leedham-Green; Irene M Leigh; Charlotte M Proby
Journal:  Arch Dermatol       Date:  2005-04

3.  Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients.

Authors:  Thomas Meyer; Rüdiger Arndt; Ingo Nindl; Claas Ulrich; Enno Christophers; Eggert Stockfleth
Journal:  Transpl Int       Date:  2003-02-06       Impact factor: 3.782

4.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

Authors:  P G Calzavara-Pinton
Journal:  J Photochem Photobiol B       Date:  1995-07       Impact factor: 6.252

5.  Metastases in dermatological patients with squamous cell carcinoma.

Authors:  R Møller; F Reymann; K Hou-Jensen
Journal:  Arch Dermatol       Date:  1979-06

Review 6.  Role of modern radiotherapy in treating skin cancer.

Authors:  Michael Veness; Shawn Richards
Journal:  Australas J Dermatol       Date:  2003-08       Impact factor: 2.875

7.  Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.

Authors:  Ahmad Jalili; Alice Pinc; Friederike Pieczkowski; Franz M Karlhofer; Georg Stingl; Stephan N Wagner
Journal:  J Dtsch Dermatol Ges       Date:  2008-12       Impact factor: 5.584

8.  Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients.

Authors:  Kathleen J Smith; Sate Hamza; Henry Skelton
Journal:  Dermatol Surg       Date:  2004-04       Impact factor: 3.398

9.  Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Authors:  Julie E Bauman; Keith D Eaton; Renato G Martins
Journal:  Arch Dermatol       Date:  2007-07

10.  Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.

Authors:  R Hitt; A Jimeno; M Rodríguez-Pinilla; J L Rodríguez-Peralto; J M Millán; A López-Martín; A Brandariz; C Peña; H Cortés-Funes
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640
View more
  37 in total

1.  Basaloid Squamous Cell Carcinoma of Scalp From A Pre-Existing Cylindroma Metastasising To Brain: A Rare Case Report.

Authors:  Impana Bellavara Diwakar; Teerthanath Srinivas; Jayaram Shetty Kolakebail; Jayaprakash Shetty; Prachi Kukreja
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.

Authors:  Christopher Metchnikoff; Thaddeus Mully; Jonathan P Singer; Jeffrey A Golden; Sarah T Arron
Journal:  J Am Acad Dermatol       Date:  2012-01-29       Impact factor: 11.527

Review 3.  Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.

Authors:  Haider K Bangash; Oscar R Colegio
Journal:  Curr Treat Options Oncol       Date:  2012-09

Review 4.  Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

Authors:  M Blomberg; S Y He; C Harwood; S T Arron; S Demehri; A Green; M M Asgari
Journal:  Br J Dermatol       Date:  2017-10-30       Impact factor: 9.302

Review 5.  Perineural growth in head and neck squamous cell carcinoma: a review.

Authors:  Joseph Roh; Thomas Muelleman; Ossama Tawfik; Sufi M Thomas
Journal:  Oral Oncol       Date:  2014-10-25       Impact factor: 5.337

6.  Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?

Authors:  Iago Gonçalves Ferreira; Ana Letícia Boff; Laura Luzzato; Paulo R Martins Souza; Mariele Bevilaqua
Journal:  Dermatol Pract Concept       Date:  2021-04-12

7.  Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.

Authors:  Q Jiao; C Liu; W Li; W Li; F Fang; Q Qian; X Zhang
Journal:  Clin Exp Immunol       Date:  2017-03-12       Impact factor: 4.330

Review 8.  Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system.

Authors:  Pooja Yesantharao; Wei Wang; Nilah M Ioannidis; Shadmehr Demehri; Alice S Whittemore; Maryam M Asgari
Journal:  Hum Immunol       Date:  2017-02-07       Impact factor: 2.850

9.  Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma.

Authors:  Janine G Einspahr; Valerie Calvert; David S Alberts; Clara Curiel-Lewandrowski; James Warneke; Robert Krouse; Steven P Stratton; Lance Liotta; Caterina Longo; Giovanni Pellacani; Giovanni Pellicani; Anil Prasad; Paul Sagerman; Yira Bermudez; Jianghong Deng; G Timothy Bowden; Emanuel F Petricoin
Journal:  Cancer Prev Res (Phila)       Date:  2012-03

Review 10.  Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.

Authors:  Samantha Tam; Neil D Gross
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.